The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6

por Fricke, Thomas, Valle-Casuso, Jose Carlos, White, Tommy E, Brandariz-Nuñez, Alberto, Bosche, William J, Reszka, Natalia, Gorelick, Robert, Diaz-Griffero, Felipe
Publicado 2013

Liver macrophage-associated inflammation correlates with SIV burden and is substantially reduced following cART

por Fisher, Bridget S., Green, Richard R., Brown, Rachel R., Wood, Matthew P., Hensley-McBain, Tiffany, Fisher, Cole, Chang, Jean, Miller, Andrew D., Bosche, William J., Lifson, Jeffrey D., Mavigner, Maud, Miller, Charlene J., Gale, Michael, Silvestri, Guido, Chahroudi, Ann, Klatt, Nichole R., Sodora, Donald L.
Publicado 2018

Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral...

por Fennessey, Christine M., Pinkevych, Mykola, Immonen, Taina T., Reynaldi, Arnold, Venturi, Vanessa, Nadella, Priyanka, Reid, Carolyn, Newman, Laura, Lipkey, Leslie, Oswald, Kelli, Bosche, William J., Trivett, Matthew T., Ohlen, Claes, Ott, David E., Estes, Jacob D., Del Prete, Gregory Q., Lifson, Jeffrey D., Davenport, Miles P., Keele, Brandon F.
Publicado 2017

Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy

por Barrenäs, Fredrik, Hansen, Scott G., Law, Lynn, Driscoll, Connor, Green, Richard R., Smith, Elise, Chang, Jean, Golez, Inah, Urion, Taryn, Peng, Xinxia, Whitmore, Leanne, Newhouse, Daniel, Hughes, Colette M., Morrow, David, Randall, Kurt T., Selseth, Andrea N., Ford, Julia C., Gilbride, Roxanne M., Randall, Bryan E., Ainslie, Emily, Oswald, Kelli, Shoemaker, Rebecca, Fast, Randy, Bosche, William J., Axthelm, Michael K., Fukazawa, Yoshinori, Pavlakis, George N., Felber, Barbara K., Fourati, Slim, Sekaly, Rafick-Pierre, Lifson, Jeffrey D., Komorowski, Jan, Kosmider, Ewelina, Shao, Danica, Song, Wenjun, Edlefsen, Paul T., Picker, Louis J., Gale, Michael
Publicado 2021